BFRI (Biofrontera Inc. Common Stock) Stock Analysis - SEC Filings

Biofrontera Inc. Common Stock (BFRI) is a publicly traded Healthcare sector company. As of May 21, 2026, BFRI trades at $0.81 with a market cap of $9.54M and a P/E ratio of -0.77. BFRI moved +0.51% today. Year to date, BFRI is +1.23%; over the trailing twelve months it is +22.43%. Its 52-week range spans $0.54 to $2.22. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces BFRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BFRI SEC filings?

Rallies organizes BFRI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BFRI Key Metrics

Key financial metrics for BFRI
MetricValue
Price$0.81
Market Cap$9.54M
P/E Ratio-0.77
EPS$-1.04
Dividend Yield0.00%
52-Week High$2.22
52-Week Low$0.54
Volume0
Avg Volume0
Revenue (TTM)$41.70M
Net Income$-10.54M
Gross Margin0.00%

Latest BFRI News

BFRI Analyst Consensus

1 analysts cover BFRI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about BFRI

Where can I find BFRI SEC filings?
Rallies organizes BFRI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BFRI 10-K and 10-Q filings?
Rallies organizes BFRI SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BFRI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BFRI. It does not provide personalized investment advice.
BFRI

BFRI